Tc Biopharm Holdings Stock Net Income
| TCBPDelisted Stock | USD 0.50 0.00 0.00% |
As of the 17th of February 2026, TC BioPharm owns the information ratio of (0.24), and Market Risk Adjusted Performance of 1.73. In connection with fundamental indicators, the technical analysis model makes it possible for you to check timely technical drivers of TC BioPharm Holdings, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from TC BioPharm's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting TC BioPharm's valuation are summarized below:TC BioPharm Holdings does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. TCBP |
Search Suggestions
| TC | TuanChe ADR | Company |
| TCBIO | Texas Capital Bancshares | Company |
| TCAAX | Thrivent Moderately Servative | Mutual Fund |
| TCV | EA Series Trust | ETF |
| TCT | TCT | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, TC BioPharm Holdings reported net income of (5.91 Million). This is 101.73% lower than that of the Biotechnology sector and 108.43% lower than that of the Health Care industry. The net income for all United States stocks is 101.03% higher than that of the company.
TCBP Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TC BioPharm's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of TC BioPharm could also be used in its relative valuation, which is a method of valuing TC BioPharm by comparing valuation metrics of similar companies.TC BioPharm is currently under evaluation in net income category among its peers.
TCBP Fundamentals
| Return On Equity | -5.77 | |||
| Return On Asset | -0.98 | |||
| Current Valuation | 1.01 M | |||
| Shares Outstanding | 512.99 K | |||
| Shares Owned By Institutions | 0.70 % | |||
| Number Of Shares Shorted | 128.4 K | |||
| Price To Book | 0.06 X | |||
| Price To Sales | 0.51 X | |||
| Gross Profit | 3.84 M | |||
| EBITDA | (13.61 M) | |||
| Net Income | (5.91 M) | |||
| Cash And Equivalents | 1.57 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 1.8 M | |||
| Current Ratio | 0.19 X | |||
| Book Value Per Share | 81.06 X | |||
| Cash Flow From Operations | (10.54 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (4,794) X | |||
| Target Price | 48.0 | |||
| Number Of Employees | 41 | |||
| Beta | 0.012 | |||
| Market Capitalization | 256.5 K | |||
| Total Asset | 8.93 M | |||
| Retained Earnings | (38.84 M) | |||
| Working Capital | 950.33 K | |||
| Net Asset | 8.93 M |
About TC BioPharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TC BioPharm Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TC BioPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TC BioPharm Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Pink Sheet
Moving against TCBP Pink Sheet
| 0.91 | USPH | US Physicalrapy | PairCorr |
| 0.89 | GS | Goldman Sachs Group | PairCorr |
| 0.87 | SLSR | Solaris Resources | PairCorr |
| 0.87 | EMMA | Emmaus Life Sciences | PairCorr |
| 0.85 | CGECF | Cogeco Inc | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in TCBP Pink Sheet
If you are still planning to invest in TC BioPharm Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |